title: Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7).
abstract: Recent studies have described an increase in the incidence of complicated pneumonia in children, primarily caused by Streptococcus pneumoniae. The objective of this study was to determine if the incidence of complicated pneumonias in total and due to different pneumococcal serotypes has changed following the introduction of routine immunization with heptavalent pneumococcal conjugate vaccine (PCV7). A retrospective review of patients admitted to the Stollery Children's Hospital in Edmonton, Alberta with complicated pneumonia between July 1, 1997 and June 30, 2007 (5 years before and after the introduction of PCV7) was completed. There were 34 children in the pre- and 68 in the post-PCV7 era (14.31 and 19.91 per 10,000 discharges, respectively, p = 0.114). Patient characteristics were not significantly different, and pneumococcus was the most common organism isolated (pre: 21% (7/34); post: 26% (18/68), p = 0.515). In patients where serotype data was available, non-vaccine pneumococcal serotypes accounted for 67% (12/18) cases in the post-PVC7 era versus 14% (1/7) in the pre-PCV7 era (p = 0.031). The incidence of non-vaccine serotypes was 0.42 and 3.51 per 10,000 discharges in the pre- and post-PCV7 eras, respectively (p = 0.020). There has been a non-significant trend towards an increase in the incidence of complicated pneumonia following the introduction of PCV7. S. pneumoniae remains the predominant organism identified with non-vaccine serotypes now accounting for almost all cases. Although it is not clear if this increase is attributable to the use of PCV7, expanding pneumococcal serotype coverage has the potential to prevent complicated pneumonia.
authors.affiliation: Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
authors.forename: Thea K
authors.initials: TK
authors.lastname: Chibuk
authors.forename: Joan L
authors.initials: JL
authors.lastname: Robinson
authors.forename: Dawn S
authors.initials: DS
authors.lastname: Hartfield
mesh_terms: D000293:Adolescent; D000416:Alberta / Q000453:epidemiology; D002648:Child; D002673:Child, Hospitalized; D002675:Child, Preschool; D005260:Female; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000453:epidemiology / Q000276:immunology* / Q000382:microbiology* / Q000517:prevention & control; D012189:Retrospective Studies; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000276:immunology / Q000302:isolation & purification*
chemical_list: D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022242:Pneumococcal Vaccines
references.citation: MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8
references.pmid: 18272956
references.citation: Lancet. 1997 Feb 8;349(9049):402
references.pmid: 9033476
references.citation: Clin Infect Dis. 2005 Jul 1;41(1):21-9
references.pmid: 15937758
references.citation: Clin Microbiol Infect. 2008 Sep;14(9):828-34
references.pmid: 18844683
references.citation: Pediatr Infect Dis J. 2006 Jun;25(6):559-60
references.pmid: 16732158
references.citation: BMC Infect Dis. 2008 Sep 25;8:129
references.pmid: 18816409
references.citation: Int J Antimicrob Agents. 2009 Oct;34(4):375-9
references.pmid: 19560902
references.citation: JAMA. 2009 Jul 8;302(2):159-67
references.pmid: 19584345
references.citation: Clin Infect Dis. 2008 Jun 1;46(11):1664-72
references.pmid: 18433334
references.citation: N Engl J Med. 2003 May 1;348(18):1737-46
references.pmid: 12724479
references.citation: Pediatrics. 2008 Aug;122(2):229-37
references.pmid: 18676537
references.citation: Pediatr Infect Dis J. 2003 Jun;22(6):499-504
references.pmid: 12799505
references.citation: Pediatrics. 2010 Jan;125(1):26-33
references.pmid: 19948570
references.citation: Scand J Infect Dis. 2009;41(3):182-7
references.pmid: 19117244
references.citation: MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):1-4
references.pmid: 19145219
references.citation: Pediatr Infect Dis J. 2006 Mar;25(3):250-4
references.pmid: 16511389
references.citation: Epidemiol Infect. 2008 Nov;136(11):1448-54
references.pmid: 18211724
references.citation: Clin Infect Dis. 2002 Feb 15;34(4):434-40
references.pmid: 11797168
references.citation: Clin Infect Dis. 2009 Jul 15;49(2):205-12
references.pmid: 19508165
references.citation: Pediatr Infect Dis J. 2008 Nov;27(11):1030-2
references.pmid: 18845981
references.citation: Clin Infect Dis. 2010 Feb 1;50(3):329-37
references.pmid: 20047478
references.citation: Eur J Pediatr. 2009 Jan;168(1):51-8
references.pmid: 18461362
references.citation: Pediatrics. 1998 Apr;101(4 Pt 1):604-11
references.pmid: 9521941
references.citation: J Infect Dis. 2007 Nov 1;196(9):1346-54
references.pmid: 17922399
references.citation: Vaccine. 2009 Jun 2;27(27):3553-60
references.pmid: 19464534
references.citation: Pediatrics. 2004 Jun;113(6):1735-40
references.pmid: 15173499
references.citation: Acta Paediatr. 2009 Feb;98(2):328-31
references.pmid: 18983440
references.citation: Pediatrics. 2002 Jul;110(1 Pt 1):1-6
references.pmid: 12093940
references.citation: Vaccine. 2009 Aug 21;27 Suppl 3:C22-4
references.pmid: 19545935
references.citation: MMWR Recomm Rep. 2000 Oct 6;49(RR-9):1-35
references.pmid: 11055835